Free Trial
NASDAQ:AFMD

Affimed (AFMD) Stock Price, News & Analysis

Affimed logo
$0.18 -0.10 (-34.95%)
As of 05/19/2025

About Affimed Stock (NASDAQ:AFMD)

Key Stats

Today's Range
$0.17
$0.24
50-Day Range
$0.09
$1.10
52-Week Range
$0.07
$5.84
Volume
22.99 million shs
Average Volume
4.59 million shs
Market Capitalization
$2.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.62
Consensus Rating
Hold

Company Overview

Affimed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

AFMD MarketRank™: 

Affimed scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Affimed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Affimed has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Affimed's stock forecast and price target.
  • Earnings Growth

    Earnings for Affimed are expected to grow in the coming year, from ($4.19) to ($2.05) per share.

  • Price to Book Value per Share Ratio

    Affimed has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Affimed's valuation and earnings.
  • Short Interest

    There is no current short interest data available for AFMD.
  • Dividend Yield

    Affimed does not currently pay a dividend.

  • Dividend Growth

    Affimed does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for AFMD.
  • Search Interest

    Only 1 people have searched for AFMD on MarketBeat in the last 30 days. This is a decrease of -95% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Affimed to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Affimed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.80% of the stock of Affimed is held by insiders.

  • Percentage Held by Institutions

    Only 30.82% of the stock of Affimed is held by institutions.

  • Read more about Affimed's insider trading history.
Receive AFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Affimed and its competitors with MarketBeat's FREE daily newsletter.

AFMD Stock News Headlines

OTC:AFMD.Q (Affimed)
Affimed Stock Price, Quotes and Forecasts
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

AFMD Stock Analysis - Frequently Asked Questions

Affimed's stock was trading at $1.19 at the beginning of 2025. Since then, AFMD shares have decreased by 84.7% and is now trading at $0.1815.

Affimed (NASDAQ:AFMD) issued its quarterly earnings results on Wednesday, November, 10th. The biopharmaceutical company reported ($1.40) earnings per share for the quarter, missing the consensus estimate of ($1.30) by $0.10. The biopharmaceutical company had revenue of $10.21 million for the quarter, compared to analyst estimates of $11.79 million. Affimed had a negative net margin of 7,836.26% and a negative trailing twelve-month return on equity of 193.84%.
Read the conference call transcript
.

Affimed shares reverse split on Monday, March 11th 2024.The 1-10 reverse split was announced on Wednesday, March 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 8th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of AFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Affimed investors own include Meta Platforms (META), NVIDIA (NVDA), Novavax (NVAX), Tesla (TSLA), Advanced Micro Devices (AMD), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
11/10/2021
Today
7/05/2025
Next Earnings (Estimated)
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AFMD
Employees
200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.62
High Stock Price Target
$10.00
Low Stock Price Target
$0.10
Potential Upside/Downside
+1,895.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$114.66 million
Net Margins
-7,836.26%
Pretax Margin
-7,837.50%

Debt

Sales & Book Value

Annual Sales
$877 thousand
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
0.04

Miscellaneous

Free Float
15,488,000
Market Cap
$2.92 million
Optionable
Optionable
Beta
2.07

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:AFMD) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners